Acer Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
N/A
Price/Sales ratio
N/A
Earnings per Share (EPS)
$0.75

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.65-1.51-1.35-0.81-3.60-8.08-1.40-1.27-2.20-1.42-0.40-3.60
Price/Sales ratio
21.7817.906.382.24-207.74398.33N/AN/A25.81N/AN/A-207.74
Price/Book Value ratio
1.343.061.692.402.293.812.203.54-18.87-2.36-0.913.81
Price/Cash Flow ratio
-4.50-1.60-1.55-0.70-3.63-10.37-1.37-1.71-241.13-1.30-0.33-3.63
Price/Free Cash Flow ratio
-4.32-1.58-1.53-0.70-3.61-10.31-1.36-1.71-171.35-1.30-0.33-3.61
Price/Earnings Growth ratio
-0.080.020.020.010.050.23-0.090.040.04-0.010.010.23
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%100%100%100%N/AN/A100%N/AN/A100%
Operating Profit Margin
-941.33%-1184.67%-473.09%-275.08%5662.97%-5024.80%N/AN/A-1265.74%N/AN/A-5024.80%
Pretax Profit Margin
-1315.03%-1183.45%-470.17%-274.68%5762.97%-4924.80%N/AN/A-1220.15%N/AN/A-4924.80%
Net Profit Margin
-1315.03%-1183.45%-470.17%-274.68%5762.97%-4924.80%N/AN/A-1168.94%N/AN/A-4924.80%
Effective Tax Rate
-28.43%-0.02%0.03%-13.00%-1.73%2.03%1.82%-0.05%4.19%-6.18%N/A-1.73%
Return on Assets
-63.47%-127.53%-83.37%-206.39%-58.24%-42.00%-134.54%-156.68%-40.62%-239.67%-327.62%-42.00%
Return On Equity
-80.94%-202.33%-125.00%-294.90%-63.55%-47.20%-157.21%-278.40%854.52%166.21%318.33%-63.55%
Return on Capital Employed
-52.03%-173.79%-125.77%-295.32%-62.44%-48.16%-159.90%-269.27%-223.14%335.91%528.50%-62.44%
Liquidity Ratios
Current Ratio
7.443.402.823.288.127.664.651.04N/AN/A0.187.66
Quick Ratio
6.903.402.723.288.127.664.651.040.920.180.127.66
Cash ratio
7.113.162.622.967.697.464.360.930.430.120.127.46
Days of Sales Outstanding
-193.95N/AN/AN/AN/AN/AN/AN/A1.44KN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/A0.010.04N/AN/A0.020.020.011.002.44N/A
Debt Equity Ratio
N/AN/A0.010.05N/AN/A0.030.04-0.22-0.69-1.69N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.010.01-0.13-1.24N/AN/A
Total Debt to Capitalization
N/AN/A0.010.05N/AN/A0.030.04-0.29-2.32N/AN/A
Interest Coverage Ratio
-5.25-7.59KN/AN/A-56.91-21.99KN/AN/AN/AN/A-162.83-21.99K
Cash Flow to Debt Ratio
N/AN/A-70.86-58.75N/AN/A-50.03-46.73-0.34-2.58N/AN/A
Company Equity Multiplier
1.271.581.491.421.091.121.161.77-21.03-0.69-0.691.12
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-4.83-11.16-4.11-3.1657.22-38.38N/AN/A-0.10N/AN/A-38.38
Free Cash Flow / Operating Cash Flow Ratio
1.041.011.001.001.001.001.001.001.401.001.001.00
Cash Flow Coverage Ratio
N/AN/A-70.86-58.75N/AN/A-50.03-46.73-0.34-2.58N/AN/A
Short Term Coverage Ratio
N/AN/A-70.86-58.75N/AN/A-112.02-62.10-0.73-12.44-19.82N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A